- Home
- CAPR vs CCBG Comparison
CAPR vs CCBG Comparison
Compare CAPR & CCBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAPR
- CCBG
- Stock Information
- Founded
- CAPR 2005
- CCBG 1895
- Country
- CAPR United States
- CCBG United States
- Employees
- CAPR N/A
- CCBG N/A
- Industry
- CAPR Biotechnology: Biological Products (No Diagnostic Substances)
- CCBG Major Banks
- Sector
- CAPR Health Care
- CCBG Finance
- Exchange
- CAPR Nasdaq
- CCBG Nasdaq
- Market Cap
- CAPR 578.4M
- CCBG 625.1M
- IPO Year
- CAPR N/A
- CCBG N/A
- Fundamental
- Price
- CAPR $15.00
- CCBG $35.49
- Analyst Decision
- CAPR Strong Buy
- CCBG Buy
- Analyst Count
- CAPR 7
- CCBG 2
- Target Price
- CAPR $39.29
- CCBG $39.00
- AVG Volume (30 Days)
- CAPR 902.1K
- CCBG 20.3K
- Earning Date
- CAPR 03-03-2025
- CCBG 01-28-2025
- Dividend Yield
- CAPR N/A
- CCBG 2.59%
- EPS Growth
- CAPR N/A
- CCBG 1.63
- EPS
- CAPR N/A
- CCBG 3.12
- Revenue
- CAPR $23,228,045.00
- CCBG $230,883,000.00
- Revenue This Year
- CAPR N/A
- CCBG N/A
- Revenue Next Year
- CAPR $74.85
- CCBG $3.65
- P/E Ratio
- CAPR N/A
- CCBG $11.38
- Revenue Growth
- CAPR 65.33
- CCBG 4.53
- 52 Week Low
- CAPR $3.52
- CCBG $25.45
- 52 Week High
- CAPR $23.40
- CCBG $40.86
- Technical
- Relative Strength Index (RSI)
- CAPR 52.56
- CCBG 39.44
- Support Level
- CAPR $14.28
- CCBG $36.73
- Resistance Level
- CAPR $16.47
- CCBG $37.44
- Average True Range (ATR)
- CAPR 1.00
- CCBG 0.85
- MACD
- CAPR 0.07
- CCBG -0.18
- Stochastic Oscillator
- CAPR 55.05
- CCBG 1.77
About CAPR Capricor Therapeutics Inc.
Capricor Therapeutics Inc is a biotechnology company focused on advancing transformative cell and exosome-based therapeutics to redefine the treatment landscape for rare diseases. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat and prevent a wide range of diseases with targeted delivery.
About CCBG Capital City Bank Group
Capital City Bank Group Inc is a United States-based group engaged in Banking services, Trust and asset management services, and Brokerage services. The company offers retail and commercial banking business in the form of traditional deposit and credit services, asset management, trust, mortgage banking, merchant services, bank cards, data processing, and securities brokerage services among others through its banking offices in Florida, Georgia, and Alabama.